Identification of Lysophosphatidylcholines and Sphingolipids as Potential Biomarkers for Acute Aortic Dissection via Serum Metabolomics.

MLA

Zhou, Xiushi, et al. “Identification of Lysophosphatidylcholines and Sphingolipids as Potential Biomarkers for Acute Aortic Dissection via Serum Metabolomics.” European Journal of Vascular and Endovascular Surgery : The Official Journal of the European Society for Vascular Surgery, vol. 57, no. 3, Mar. 2019, pp. 434–41. EBSCOhost, https://doi.org/10.1016/j.ejvs.2018.07.004.

APA

Zhou, X., Wang, R., Zhang, T., Liu, F., Zhang, W., Wang, G., Gu, G., Han, Q., Xu, D., Yao, C., Guo, D., Fu, W., Qi, Y., & Wang, L. (2019). Identification of Lysophosphatidylcholines and Sphingolipids as Potential Biomarkers for Acute Aortic Dissection via Serum Metabolomics. European Journal of Vascular and Endovascular Surgery : The Official Journal of the European Society for Vascular Surgery, 57(3), 434–441. https://doi.org/10.1016/j.ejvs.2018.07.004

Chicago

Zhou, Xiushi, Renping Wang, Tian Zhang, Fei Liu, Wei Zhang, Guili Wang, Guorong Gu, et al. 2019. “Identification of Lysophosphatidylcholines and Sphingolipids as Potential Biomarkers for Acute Aortic Dissection via Serum Metabolomics.” European Journal of Vascular and Endovascular Surgery : The Official Journal of the European Society for Vascular Surgery 57 (3): 434–41. doi:10.1016/j.ejvs.2018.07.004.